EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $61,000 | -59.1% | 3,900 | -40.8% | 0.00% | – |
| Q1 2022 | $149,000 | +2880.0% | 6,591 | +2612.3% | 0.00% | – |
| Q3 2021 | $5,000 | -99.7% | 243 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $1,666,000 | +192.8% | 73,769 | +160.2% | 0.01% | +200.0% |
| Q4 2020 | $569,000 | +511.8% | 28,356 | +642.9% | 0.00% | – |
| Q3 2020 | $93,000 | -87.7% | 3,817 | -88.0% | 0.00% | -100.0% |
| Q2 2020 | $756,000 | +172.9% | 31,859 | +102.9% | 0.00% | +200.0% |
| Q4 2019 | $277,000 | -54.5% | 15,700 | -54.4% | 0.00% | -66.7% |
| Q3 2019 | $609,000 | -34.4% | 34,429 | -11.8% | 0.00% | -25.0% |
| Q1 2019 | $929,000 | +3.3% | 39,035 | -14.6% | 0.00% | -33.3% |
| Q4 2018 | $899,000 | +39.2% | 45,709 | +25.3% | 0.01% | +50.0% |
| Q3 2018 | $646,000 | – | 36,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |